SCHEMBL24310089

SCHEMBL24310089

CCc1c(Oc2cccc(N3CCN(C)CC3)c2Cl)nc(NSc2cnn(C)c2)nc1-c1ccccc1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 2/20 0.35
▸ DRD3 P35462 2/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ DRD4 P21917 1/20 0.35
▸ HTR2A P28223 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ BRD9 Q9H8M2 2/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ BRPF1 P55201 1/20 0.33
▸ IGF1R P08069 1/20 0.31
▸ PAK1 Q13153 3/20 0.31
▸ EGFR P00533 1/20 0.31
▸ CSF1R P07333 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ HTR6 P50406 1/20 0.30
▸ MAP3K7 O43318 1/20 0.30
▸ MAP2K1 Q02750 1/20 0.30
▸ PTPN11 Q06124 1/20 0.30
▸ BRD7 Q9NPI1 1/20 0.30
▸ TNIK Q9UKE5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310049 0.92 PAK1 (0.36) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24310709 0.92 DRD2 (0.33) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24309321 0.92 ALDH1A1 (0.36) IGF1R
SCHEMBL24309910 0.92 HTR6 (0.33) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24310065 0.91 DRD2 (0.37) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24309536 0.91 BRPF1 (0.34) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24309479 0.91 HTR1A (0.33) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24310425 0.90 DRD2 (0.35) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24310712 0.89 AXL (0.33) DRD2DRD3HTR1ADRD4HTR2A
SCHEMBL24310513 0.89 MEN1 (0.33) DRD2DRD3HTR1ADRD4HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback